These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2538262)

  • 1. Studies on the chemotherapy with 5-fluorouracil in transcatheter arterial chemoembolization (TAE) treated patients with resectable or non-resectable hepatocellular carcinoma. Osaka Study Group on Hepatocellular Carcinoma.
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S29-32. PubMed ID: 2538262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma.
    Hirai K; Kawazoe Y; Yamashita K; Aoki Y; Fujimoto T; Sakai T; Majima Y; Abe M; Tanikawa K
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S37-41. PubMed ID: 2538264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.
    Hashimoto N; Kawai S; Mikuriya S; Oda T; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Yumoto Y; Makino M
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S21-5. PubMed ID: 2466582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
    Kawai S; Tani M; Mikuriya S; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Jinno K; Makino M; Oda T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):227-32. PubMed ID: 2154160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Pelletier G; Roche A; Ink O; Anciaux ML; Derhy S; Rougier P; Lenoir C; Attali P; Etienne JP
    J Hepatol; 1990 Sep; 11(2):181-4. PubMed ID: 2174933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
    Ohishi H; Yoshimura H; Uchida H; Sakaguchi H; Yoshioka T; Ohue S; Matsui T; Takaya A; Tsujii T
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S33-6. PubMed ID: 2538263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial.
    Yoshimi F; Nagao T; Inoue S; Kawano N; Muto T; Gunji T; Ohnishi S; Imawari M
    Hepatology; 1992 Sep; 16(3):702-6. PubMed ID: 1324216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.
    Zhang YF; Wei W; Guo ZX; Wang JH; Shi M; Guo RP
    Jpn J Clin Oncol; 2015 Sep; 45(9):837-43. PubMed ID: 26079139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Yang CF; Ho YZ; Chang JM; Chiang RH; Lai KH; Lee SD; Tsai YT; Lui WY; Liu TJ; Chen GH
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S26-8. PubMed ID: 2538261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial.
    Lin DY; Liaw YF; Lee TY; Lai CM
    Gastroenterology; 1988 Feb; 94(2):453-6. PubMed ID: 2826285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
    Ikeda M; Okada S; Yamamoto S; Sato T; Ueno H; Okusaka T; Kuriyama H; Takayasu K; Furukawa H; Iwata R
    Jpn J Clin Oncol; 2002 Nov; 32(11):455-60. PubMed ID: 12499417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee PC; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Chau GY; Chiang JH; Lui WY; Lee SD; Wu JC
    Liver Int; 2004 Oct; 24(5):419-24. PubMed ID: 15482337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma].
    Tanikawa K; Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Abe M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1930-7. PubMed ID: 2996439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Okamura J; Ogawa M; Ohashi Y; Tani M; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S1-6. PubMed ID: 1281041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S; Tanaka K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Hatooka M; Kawaoka T; Aikata H; Morio K; Kobayashi T; Hiramatsu A; Imamura M; Kawakami Y; Murakami E; Waki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
    Anticancer Res; 2016 Jul; 36(7):3523-9. PubMed ID: 27354618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter oily chemoembolization of hepatocellular carcinoma.
    Nakamura H; Hashimoto T; Oi H; Sawada S
    Radiology; 1989 Mar; 170(3 Pt 1):783-6. PubMed ID: 2536946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
    Iwamiya T; Sawada S; Morioka N; Tanigawa N; Kobayashi M; Nakamura K; Okuda Y; Hashimoto M; Ohta Y; Kawasaki H
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2213-7. PubMed ID: 1332626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.